C0027361||Individual
C0596255||Carbon Ions
C0596255||Carbon ions
C0022023||ion species
C2985551||charged particle radiotherapy
C0027361||interindividual
C0683971||general population
C0456984||clinical outcomes
C1522449||radiotherapy
C3494442||carbon ion therapy
C1522449||radiotherapy
C0027361||individual
C0729631||carbon-13
C0022023||ions
C1518997||peripheral blood lymphocytes
C0027361||individuals
C1511667||DNA double strand breaks
C1511667||double strand breaks
C0008625||chromosomal aberrations
C0008625||chromosomal aberrations
C1511667||double strand breaks
C1511667||double strand breaks
C0008625||chromosomal aberrations
C0085187||telomere
C0007709||centromere
C0162789||fluorescence in situ hybridization
C0162789||telomere / centromere - fluorescence in situ hybridization
C1522449||fractionated radiotherapy
C1511667||double strand breaks
C0027361||individuals
C0027361||individuals
C0017428||genome
C0027361||individuals
C0015333||exposure to
C0007009||carbon
C1522449||irradiation
C2985557||γ-irradiation
C1511667||double strand breaks
C3494442||carbon irradiation
C1511667||double strand breaks
C2985557||γ-irradiation
C0752095||cytogenetic technique
C0162789||multicolor-FISH
C4042795||hypo
C1518010||low doses
C1514688||IR-induced DNA damage
C0008625||chromosomal aberrations
C0919532||genomic instability
C0007634||cellular
C0479513||IR exposure
C0027627||secondary cancers
C1522449||radiotherapy